Post-Registration Clinical Monitoring (PCM) Report in Russia: Preparation and Filing Support
Annual Post-Registration Clinical Monitoring (PCM) reports are mandatory for Class 3 and implantable Class 2b medical devices in Russia, requiring manufacturers and authorized representatives to demonstrate real-world device safety through Russian clinical data or risk losing their registration certificate.
Чтобы начать процесс сертификации уже сегодня
Свяжитесь с нами удобным способом:
8 812-309-89-10
Заявка на сайте 
Мы работаем с российскими и зарубежными производителями, обеспечивая полную конфиденциальность. Помогаем ускорить получение регистрационного удостоверения и избежать типичных ошибок.
If you market high-risk medical devices in Russia, you may be required to submit an annual Post-Registration Clinical Monitoring report to Roszdravnadzor. In Russian practice this annual report is commonly referred to as the “PCM report” (PCM is the accepted acronym used in the Russian regulatory environment). This requirement applies primarily to high-risk devices and is now directly linked to the continued validity of your Russian registration certificate.
Our team Unified center of expertise and certification “Quality” supports Russian manufacturers and authorized representatives of foreign manufacturers with end-to-end PCM (Post-Registration Clinical Monitoring) report preparation and submission, aligned with Russia’s current regulatory expectations and real-world Roszdravnadzor practice.
Do I have to submit a Post-Registration Clinical Monitoring report for my medical device in Russia?
Mandatory annual post-registration clinical monitoring report applies to:
- Risk Class 3 medical devices, and
- Implantable Risk Class 2b medical devices.
If your medical device is outside these categories, annual PKM reporting is typically not required by default, but you still remain responsible for post-market safety monitoring and adverse event reporting when relevant.
Which medical devices fall under mandatory post-registration clinical monitoring report in Russia?
| Device category | PCM annual report required? | Typical examples |
|---|---|---|
| Risk Class 3 | Yes | High-risk IVD tests (HIV/HBV/HCV/syphilis; donor blood/organs), implantable pacemakers/ICDs, spinal cord stimulators, artificial heart valves, hemodialysis systems; implantables contacting heart/central circulation/CNS |
| Implantable Risk Class 2b | Yes | Titanium plates/screws/pins and intramedullary nails, intraocular lenses, peripheral vascular stents/valves, joint endoprostheses (hip/knee) where Class 3 criteria don’t apply, surgical mesh implants (long-term; no heart/CNS contact) |
| Risk Class 1 and 2a | No | Typically exempt from PKM annual reporting |
| Non-implantable Risk Class 2b | No | Typically exempt from PKM annual reporting |
What is a Post-Registration Clinical Monitoring report in Russia?
Post-Registration Clinical Monitoring (PCM) is a systematic process of collecting and analyzing clinical data after registration and Russian market entry to confirm that the medical device remains safe and clinically effective in real-world use, detect new risks early, and implement corrective actions.
The PCM Post-Registration Clinical Monitoring report is the annual regulatory deliverable summarizing results for the reporting period including:
- what clinical data were collected;
- what incidents/adverse signals were detected and how they were analyzed;
- what conclusions were reached on safety and performance (risk-benefit profile);
- what CAPA (Corrective and Preventive Actions) were implemented or planned.
Practical meaning: You show Roszdravnadzor you are controlling clinical risks and managing the device lifecycle, not just maintaining paperwork.
Which regulations govern Post-Registration Clinical Monitoring report in Russia?
Your annual Post-Registration Clinical Monitoring report is based on the following core acts:
- Government Decree of the Russian Federation No. 1684 (dated 30.11.2024) – effective March 1, 2025.
- Ministry of Health Order No. 980n (dated 15.09.2020) – rules for medical device safety monitoring.
- Ministry of Health Order No. 1113n (dated 19.10.2020) – sets the procedure and timelines for submitting adverse event information to Roszdravnadzor (this is a related, but separate reporting track).
What happens if I don’t file the Post-Registration Clinical Monitoring report in Russia?
Starting March 1, 2025, failure to file the Post-Registration Clinical Monitoring report can trigger regulatory actions up to suspension and cancellation of the Russian registration certificate for your medical device.
Typical regulatory sequence
| Step | Regulator action | Timeline |
|---|---|---|
| 1 | Notice requesting the report | 10 business days to remedy |
| 2 | Suspension of the registration certificate | 30 business days |
| 3 | Cancellation of the registration certificate | If still not filed after suspension |
What must be included in a compliant Post-Registration Clinical Monitoring report in Russia?
A well-prepared Post-Registration Clinical Monitoring (PCM) report typically covers:
- Administrative & device identification: certificate holder (or authorized representative), device name/model/variants, registration certificate number, reporting period.
- Monitoring plan and methodology: data sources, evaluation criteria, assumptions and limitations.
- Clinical data for the reporting period: exposure and use volume, observations and outcomes, population/indications (within allowed format).
- Adverse events & safety signals: incident & signal analysis and comparison to expected risk profile.
- Risk–benefit evaluation: confirmation or refinement of safety and performance conclusions.
- CAPA: corrective and preventive actions taken or planned (documents, IFU, controls, training, user communications).
Important reminder: adverse event notifications under Order No. 1113n are treated as a separate reporting pathway, even though they are closely connected to post-market safety monitoring.
When is the Post-Registration Clinical Monitoring report due in Russia?
Filing frequency and duration:
- Frequency: once per year (annually)
- Deadline: by February 1 of the year following the reporting period
- Monitoring period: typically at least 3 years from device registration (Roszdravnadzor may extend).
Quick deadline checklist
| Question | What to do |
|---|---|
| How often do we file? | Once per year |
| How many years? | Usually 3 years (extension possible) |
| What is the hard deadline? | February 1 (following year) |
| How to reduce last-minute risk? | Target submission by January 31 and keep a buffer for technical issues or corrections |
Who must submit the Post-Registration Clinical Monitoring report in Russia?
The Post-Registration Clinical Monitoring (PCM) report is submitted by:
- the manufacturer / registration certificate holder, or
- the authorized representative (for foreign manufacturers).
Critical rule for foreign manufacturers
Authorized representatives for foreign medical device manufacturers must include clinical data obtained in Russia. Submitting only non-Russian (foreign) data is not acceptable.
How do I submit the Post-Registration Clinical Monitoring report to Roszdravnadzor?
You can submit the Post-Registration Clinical Monitoring (PCM) report in electronic or paper form. Electronic submission is typically recommended.
Electronic submission (recommended)
- Submission through the Roszdravnadzor online account.
- Login via Gosuslugi using an enhanced qualified e-signature.
- Format requirements: PDF, up to 100 MB, 300 dpi, with a searchable text layer.
Paper submission
- In person via Roszdravnadzor’s office intake, or
- By Russian Post (registered mail with delivery confirmation).
Professional support in Post-Registration Clinical Monitoring report for medical devices in Russia
Unified center of expertise and certification “Quality” (LLC UCEC “Quality”) supports foreign manufacturers with end-to-end preparation of post-registration clinical monitoring (PCM) reporting, including:
- a rapid audit of your PCM setup (what exists, what’s missing, deadline/data risks);
- development or updates of the monitoring plan and clinical data collection logic for your specific device;
- report drafting (clinical data, analysis, conclusions, risk–benefit rationale, CAPA);
- consistency checks against your registration dossier, IFU/labeling, and prior safety notifications;
- formatting for correct upload and support through confirmation of acceptance.
Meeting Post-Registration Clinical Monitoring (PCM) report requirements is not only about formal compliance – it is a practical safeguard for patient safety and for preserving your right to lawfully circulate the device in Russia.
Need help with a Russia-ready Post-Registration Clinical Monitoring (PCM) report? We can assess your medical device category, confirm the reporting scope, and prepare a regulator-defensible report package aligned with Roszdravnadzor practice.
Почему выбирают ООО «ЕЦЭС КВОЛИТИ»
Гарантии результата
- Фиксированные сроки, основанные на реальном опыте
- Прозрачное ценообразование
- Страхование ответственности и юридическая защита клиентов
Комплексный подход
- Предварительный аудит документации
- Разработка индивидуальной стратегии в зависимости от класса риска
- Полное сопровождение процесса, включая юридическую поддержку
Профессиональная команда
- Специалисты по техническому регулированию и ГОСТ
- Юристы, специализирующиеся на здравоохранении
- Консультанты по СМК (ИСО 13485) и сертификации
Часто задаваемые вопросы (FAQ)
Do I need to submit a Post-Registration Clinical Monitoring report for my medical device in Russia?
Yes, if your medical device is classified as Risk Class 3 or is an implantable Risk Class 2b device. These high-risk devices require mandatory annual Post-Registration Clinical Monitoring reports to be submitted to Roszdravnadzor. If your device falls into Class 1, Class 2a, or is a non-implantable Class 2b device, you're typically exempt from annual PCM reporting, though you still need to maintain post-market safety monitoring.
What happens if I don't file my Post-Registration Clinical Monitoring report on time?
There are some serious consequences if you don't file your Post-Registration Clinical Monitoring report on time. Starting March 1, 2025, failure to submit your PCM report can lead to suspension and eventual cancellation of your Russian registration certificate. Roszdravnadzor follows a three-step process: first, they'll give you 10 business days to remedy the situation; second, they'll suspend your certificate for 30 business days; and third, if you still haven't filed, they'll cancel your registration certificate entirely.
When is the deadline to submit my annual Post-Registration Clinical Monitoring report?
The deadline to submit your annual Post-Registration Clinical Monitoring report in Russia is February 1st of the year following your reporting period. For example, for data collected during 2024, you'd need to submit your report by February 1, 2025. It's recommended to target submission by January 31st to give yourself a buffer for any technical issues or last-minute corrections.
Can I use clinical data from outside Russia in my Post-Registration Clinical Monitoring report (PCM)?
Yes, but not exclusively. If you're a foreign manufacturer or authorized representative, you must include clinical data obtained in Russia. Submitting only non-Russian (foreign) data is not acceptable to Roszdravnadzor. Your report needs to reflect real-world Russian market experience with your device.
How long do I need to submit Post-Registration Clinical Monitoring reports for my device?
Typically for at least 3 years from your medical device registration. The monitoring period usually runs for three years, though Roszdravnadzor may extend this period depending on the device type and any safety concerns. You'll need to submit one report annually during this period.
Is electronic submission of Post-Registration Clinical Monitoring reports accepted in Russia?
Yes, and it's actually the recommended method. You can submit electronically through your Roszdravnadzor online account by logging in via Gosuslugi using an enhanced qualified e-signature. Your report must be in PDF format, up to 100 MB, at 300 dpi resolution, with a searchable text layer. Paper submission is also possible but less common.
Are pacemakers and ICDs subject to Post-Registration Clinical Monitoring reporting requirements?
Yes, absolutely. Implantable pacemakers and ICDs (implantable cardioverter-defibrillators) are classified as Risk Class 3 medical devices because they contact the heart and central circulation. All Class 3 devices require mandatory annual PCM reports to Roszdravnadzor.
Do orthopedic implants like titanium plates require Post-Registration Clinical Monitoring reports in Russia?
Yes, they do. Titanium plates, screws, pins, and intramedullary nails are typically classified as implantable Risk Class 2b devices. Even though they're not Class 3, because they're implantable devices in the 2b category, they fall under the mandatory annual PCM reporting requirement.
What should be included in a compliant Post-Registration Clinical Monitoring report in Russia?
A compliant Post-Registration Clinical Monitoring report (PCM report) in Russia must include several key sections: administrative and device identification information, your monitoring plan and methodology, clinical data from the reporting period, adverse events and safety signal analysis, risk-benefit evaluation showing the device remains safe and effective, and any corrective and preventive actions (CAPA) you've taken or planned. The report demonstrates you're actively managing clinical risks, not just maintaining paperwork.
Who is responsible for submitting the Post-Registration Clinical Monitoring report to Roszdravnadzor?
The Post-Registration Clinical Monitoring report (PCM report) in Russia must be submitted by either the manufacturer/registration certificate holder or the authorized representative for foreign manufacturers. If you're a foreign manufacturer operating in Russia, your authorized representative will handle the submission, but remember - they must include Russian clinical data, not just data from your home market.
What is Post-Registration Clinical Monitoring in Russia?
Post-Registration Clinical Monitoring (PCM) in Russia is a systematic process of collecting and analyzing clinical data after your medical device enters the Russian market. It confirms that your device remains safe and clinically effective in real-world use, helps detect new risks early, and enables you to implement corrective actions when needed. Essentially, it's ongoing surveillance that demonstrates you're actively managing your device's lifecycle and protecting patient safety, not just fulfilling a paperwork requirement.
What is a Post-Registration Clinical Monitoring report and why do I need one for my medical devices in Russia?
The Post-Registration Clinical Monitoring report (PCM report) is your annual regulatory deliverable to Roszdravnadzor that summarizes everything you've learned about your device's performance during the reporting period. It shows what clinical data you collected, what incidents or safety signals you detected and analyzed, what conclusions you reached about the device's risk-benefit profile, and what corrective and preventive actions you've implemented or planned. You need it because it's now directly linked to keeping your Russian registration certificate valid.
Get Expert Advice from Our Specialists
Our experts are ready to help. Contact us now for professional guidance, and we’ll tailor the perfect solution for your needs.